European Commission Promotes Exchanges Between Industry and Academia

Researchers gathered in Brussels to learn more about an FP7 Marie Curie scheme providing €400 million between now and 2013 for staff exchanges between businesses and universities. The "Marie Curie Industry-Academia Partnerships and Pathways" scheme is particularly designed to involve small businesses, which make up the bulk of European companies, as it opens doors to using research results that can help them develop. The conference will showcase past successes of such industry/academia partnerships, examine the barriers that currently exist to such movement between public and private sectors and offer workshops to help participants design top quality research partnerships and make the most of any future contract under the scheme.

"A knowledge based economy is all about its people. Making it easier to move between the public and private sectors is a challenge for all of Europe, and I think that the Marie Curie Industry-Academia Partnerships and Pathways action blazes a trail, which other research funders can follow" said European Science and Research Commissioner Janez Potočnik speaking at the first such conference in Brussels today.

Challenges for science and technology today are the quality of those carrying out the research, and the ability of the knowledge they generate to be used to further economic development and quality of life. The Marie Curie Actions, financed by the "People" specific programme of the EU's 7th Framework Programme, are designed to strengthen the human potential in research and technology in Europe. The Marie Curie Industry-Academia Partnerships and Pathways stimulate mobility between the public and private sectors and promote staff exchange through joint research partnerships.

The scheme is open to all organisations active in research, and the partnerships consist of at least one private and one public research organisation and at least two countries taking part in the Framework Programme. Support is provided for exchange of know-how and experience through two-way secondments of research staff; research and networking activities; recruitment of experienced researchers from outside the partnership; organisation of workshops and conferences and, for SMEs, research equipment. Funding is typically for 4 years and is up to 100% of the costs of the project; no matching financing is required.

The second call for proposals is now open with a deadline of 25/03/2008. The budget share for the current call is €45 million.

The Marie Curie IAPP scheme is an important potential source of research funding for the private sector, especially SMEs; it is the only action in which a single SME can apply for Community research funding with a single university partner. IAPP consortia are small, most typically comprising 1 or 2 public sector institutions with a single private sector partner.

The IAPP scheme follows on from the successful "Transfer of Knowledge Industry Academia Partnerships" scheme in the 6th Framework Programme. Many successful research collaborations were formed under the previous scheme and some of these are present at the conference to share their experiences and advise on how to get the most out of the partnership.

Among those present is Professor Anil Kokaram of Trinity College Dublin who along with a British company, The Foundry, won a 2007 Scientific and Engineering Award® from the Academy of Motion Picture Arts and Sciences® for their research into post-production software supported by their FP6 contract. The Foundry has sent staff to Dublin to study the latest research in 3D imaging processing and a research fellow from Trinity College has gained valuable commercial experience in the industry.

Also presenting her research was Dr Julie Maguire of Daithi O'Murchu Marine Research Station in Ireland. She coordinates a project with 5 partners in Ireland, Norway and Italy. They are researching genetic selection techniques to overcome problems of inconsistencies in the quantity and quality of shellfish supplies. Julie said of the collaboration "we will definitely want to continue working together and are now looking for new opportunities".

For further information, please visit:

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...